Co-Catalyzed Diboration of Glycals and Selective Functionalization for the Synthesis of Diverse C-Glycosides
Journal of the American Chemical Society · 18.11.2026
DOI: 10.1021/jacs.6c18953 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 18.11.2026. Verfasst von Mao-Yun Lyu und 2 weiteren Autor:innen. Die Arbeit nennt 93 Literaturangaben. Gefördert von: Indiana University, National Institutes of Health.
Abstract (Originalsprache)
The stereoselective synthesis of C-glycosides is an important objective because of the significance of these compounds. Reported here is a strategy for accessing 1,2-bisborylglycosides, which serve as useful intermediates for diverse glycoside syntheses. The synthesis of 1,2-bisborylglycosides was achieved through the development of a new method for 1,2-diboration of glycals. Moreover, the regioselective modification of one of the C–B bonds could be carried out by cross coupling or selective single-electron oxidation of a borate anion complex to generate a radical followed by capture with various SOMOphiles. The overall process leads to the synthesis of C-glycosides that are not readily accessible via other methods.
Förderung
- Indiana University
- National Institutes of Health
Zitieren
APA
Lyu, M., Malka, D., & Brown, M. K. (2026). Co-Catalyzed Diboration of Glycals and Selective Functionalization for the Synthesis of Diverse C-Glycosides. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.6c18953
Vancouver
Lyu M, Malka D, Brown MK. Co-Catalyzed Diboration of Glycals and Selective Functionalization for the Synthesis of Diverse C-Glycosides. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.6c18953
BibTeX
@article{Lyu2026,
author = {Lyu, Mao-Yun and Malka, Danielle and Brown, M. Kevin},
title = {Co-Catalyzed Diboration of Glycals and Selective Functionalization for the Synthesis of Diverse C-Glycosides},
journal = {Journal of the American Chemical Society},
year = {2026},
doi = {10.1021/jacs.6c18953}
}
EUVIMED